LANDONI, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 15.789
AS - Asia 9.322
EU - Europa 7.443
SA - Sud America 1.741
AF - Africa 173
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 13
Totale 34.501
Nazione #
US - Stati Uniti d'America 15.453
SG - Singapore 3.736
HK - Hong Kong 1.970
CN - Cina 1.878
IT - Italia 1.647
RU - Federazione Russa 1.647
BR - Brasile 1.414
SE - Svezia 968
IE - Irlanda 928
DE - Germania 844
VN - Vietnam 836
UA - Ucraina 362
GB - Regno Unito 299
CA - Canada 207
IN - India 175
FI - Finlandia 166
AR - Argentina 138
ID - Indonesia 125
FR - Francia 122
KR - Corea 122
BD - Bangladesh 97
AT - Austria 93
MX - Messico 92
ZA - Sudafrica 88
NL - Olanda 85
TR - Turchia 71
JP - Giappone 67
IQ - Iraq 51
EC - Ecuador 45
ES - Italia 45
PL - Polonia 42
DK - Danimarca 40
CO - Colombia 33
PY - Paraguay 26
CL - Cile 25
BE - Belgio 24
VE - Venezuela 24
SK - Slovacchia (Repubblica Slovacca) 22
CH - Svizzera 21
PK - Pakistan 19
IR - Iran 17
MA - Marocco 17
SA - Arabia Saudita 17
PE - Perù 16
AU - Australia 14
UY - Uruguay 14
AE - Emirati Arabi Uniti 13
CZ - Repubblica Ceca 13
EG - Egitto 13
PH - Filippine 13
UZ - Uzbekistan 13
KE - Kenya 12
RO - Romania 12
TN - Tunisia 12
JO - Giordania 11
BG - Bulgaria 10
IL - Israele 10
LT - Lituania 10
AL - Albania 9
EU - Europa 8
KG - Kirghizistan 8
NG - Nigeria 8
TH - Thailandia 8
HN - Honduras 7
KZ - Kazakistan 7
NP - Nepal 7
RS - Serbia 7
AZ - Azerbaigian 6
BO - Bolivia 6
DO - Repubblica Dominicana 6
PT - Portogallo 6
TW - Taiwan 6
DZ - Algeria 5
JM - Giamaica 5
MN - Mongolia 5
CR - Costa Rica 4
GR - Grecia 4
HR - Croazia 4
KW - Kuwait 4
MU - Mauritius 4
MY - Malesia 4
NZ - Nuova Zelanda 4
OM - Oman 4
PA - Panama 4
PS - Palestinian Territory 4
QA - Qatar 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
SC - Seychelles 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
ET - Etiopia 2
GD - Grenada 2
GE - Georgia 2
GT - Guatemala 2
LB - Libano 2
Totale 34.477
Città #
Singapore 2.240
Ann Arbor 2.072
Hong Kong 1.951
Fairfield 1.397
Ashburn 1.368
Woodbridge 964
Dublin 890
Houston 771
Wilmington 691
Chandler 636
Santa Clara 526
Seattle 510
New York 507
Cambridge 501
Princeton 442
Frankfurt am Main 427
Milan 426
Beijing 331
Jacksonville 293
Dearborn 277
Hefei 267
Los Angeles 230
Ho Chi Minh City 206
Dallas 203
Lawrence 197
Chicago 171
Altamura 167
The Dalles 144
Hanoi 143
Moscow 140
São Paulo 130
Boardman 128
San Diego 119
Seoul 116
Nanjing 105
Buffalo 102
Shanghai 98
Helsinki 91
Jakarta 90
Dong Ket 89
Andover 82
London 82
Guangzhou 81
Rome 80
Toronto 78
Munich 74
Hamburg 73
Nuremberg 60
Fremont 59
Vienna 58
Tokyo 52
Rio de Janeiro 49
Salt Lake City 49
Lachine 41
Atlanta 37
Brooklyn 37
Johannesburg 36
Tianjin 35
Norwalk 33
Council Bluffs 31
Curitiba 31
Lissone 30
Montreal 30
Falls Church 29
Nanchang 29
Phoenix 29
Brasília 28
Chennai 28
Shenyang 28
Warsaw 28
Bologna 27
Denver 25
Boston 24
Haiphong 24
Porto Alegre 24
Elk Grove Village 23
Jinan 23
Mumbai 23
San Francisco 23
San Jose 23
Shenzhen 23
Stockholm 23
Hebei 22
Monza 22
Turin 22
Bratislava 21
Changsha 21
Genova 21
Pune 21
Da Nang 20
Biên Hòa 19
Mexico City 19
Tampa 19
Zhengzhou 19
Brussels 18
Florence 18
Hangzhou 18
Ottawa 18
Quito 18
Thái Bình 18
Totale 22.212
Nome #
High-dose epirubicin in patients with advanced or recurrent uterine sarcoma 546
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery 469
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 387
Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3 385
Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms 373
Genomic and epigenomic profile of uterine smooth muscle tumors of uncertain malignant potential (Stumps) revealed similarities and differences with leiomyomas and leiomyosarcomas 353
Prevalence of human papillomavirus (HPV) and other sexually transmitted infections (STIS) among italian women referred for a colposcopy 348
Erratum: Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (Annals of Oncology (2017) 28 (iv72-iv83) DOI: 10.1093/annonc/mdx220) 330
Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers 311
Clinical outcome of patients with malignant tumors associated with mature cystic teratomas of the ovary: A retrospective multicenter Italian study 310
Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis 309
Standard ultra-staging compared to one-step nucleic acid amplification for the detection of sentinel lymph node metastasis in endometrial cancer patients: a retrospective cohort comparison 298
Two ultrastaging protocols for the detection of lymph node metastases in early-stage cervical and endometrial cancers 278
European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer 261
Prevalence of Chlamydia trachomatis Infection, Serovar Distribution and Co-Infections with Seven High-Risk HPV Types among Italian Women with a Recent History of Abnormal Cervical Cytology 256
The impact of the type of nodal assessment on prognosis in patients with high-intermediate and high-risk ESMO/ESGO/ESTRO group endometrial cancer. A multicenter Italian study 250
Imact of bevacizumab-containing primary treatment on outcome of recurrent ovarian cancer: An Italian study 247
Lymph node evaluation in high-risk early stage endometrial cancer: A multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy 245
Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer 244
The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy 234
The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis 229
Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trial 224
Dose-dense neoadjuvant chemotherapy with paclitaxel and carboplatin in cervical cancer: Efficacy on pathological response 224
The clinical significance of the tumor marker CA-125 222
Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: A prospective randomized study 218
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 218
An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective 213
Uterine leiomyosarcoma: analysis of treatment failures and survival 210
Onclarity Human Papillomavirus Extended Genotyping in the Management of Cervical Intraepithelial Neoplasia 2+ Lesions 207
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 201
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study 199
Evaluation of Human Papilloma Virus (HPV) Genotyping and Viral Load Determination as Diagnostic Biomarkers of Cervical Cancer Risk 196
Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study 194
Diffusion-weighted MR imaging in assessing cervical tumour response to nonsurgical therapy 194
Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma 194
Accuracy of Human Papillomavirus (HPV) Testing on Urine and Vaginal Self-Samples Compared to Clinician-Collected Cervical Sample in Women Referred to Colposcopy 190
Borderline ovarian cancer 190
Cisplatin-, epirubicin- and paclitaxel-containing chemotherapy in uterine adenocarcinoma 189
Chemo-conization in early cervical cancer 185
Platinum-based neoadjuvant chemotherapy followed by radical surgery for cervical carcinoma international federation of gynecology and obstetrics stage IB2-IIB 185
Endometrial stromal sarcoma: analysis of treatment failures and survival 184
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer 184
Risk-reducing salpingo-oophorectomy in women at higher risk of ovarian and breast cancer: A single institution prospective series 183
Neoadjuvant platinum-based chemotherapy followed by radical hysterectomy for stage Ib2-IIb adenocarcinoma of the uterine cervix – An Italian multicenter retrospective study 183
Intense neoadjuvant chemotherapy with cisplatin and epirubicin for advanced or bulky cervical and vaginal adenocarcinoma 182
Brachytherapy for isolated vaginal recurrences from endometrial carcinoma 182
Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy 181
Evaluation of BD Onclarity™ HPV Assay on Self-Collected Vaginal and First-Void Urine Samples as Compared to Clinician-Collected Cervical Samples: A Pilot Study 179
Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer 179
Clinical correlates of in vitro drug sensitivities of ovarian cancer cells 179
Neoadjuvant chemotherapy prior to pelvic exenteration in patients with recurrent cervical cancer: Single institution experience 178
Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer 178
Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy 177
Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients 177
Association between physical activity and menstrual cycle disorders in young athletes 175
Robotic Surgery: Changing the Surgical Approach for Endometrial Cancer in a Referral Cancer Center 175
Early oral versus "traditional" postoperative feeding in gynecologic oncology patients undergoing intestinal resection: A randomized controlled trial 175
Cisplatin, vinblastine, and bleomycin combination chemotherapy in metastatic granulosa cell tumor of the ovary 175
Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis 174
A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study 173
Fertility outcomes in stage I ovarian immature teratomas 171
The clinical implementation of primary HPV screening 170
Copy number alterations in stage I epithelial ovarian cancer highlight three genomic patterns associated with prognosis 170
Pre-chemotherapy hemoglobin levels and survival in patients with advanced epithelial ovarian cancer who received a first-line taxane/platinum-based regimen: Results of a multicenter retrospective Italian study 168
European society of gynaecological oncology guidelines for the management of patients with Vulvar cancer 168
Evaluation of two alternative non-alcohol-based media for the suspension of self-collected vaginal swabs for HPV testing in cervical cancer screening 167
Cancer in pregnancy: Proposal of an italian multicenter study. gynecologic oncology group of the italian society of gynecology and obstetrics (sigo) 166
Fertility-Sparing Options in Young Women with Cervical Cancer 165
Procoagulant and fibrinolytic activity of human ovarian carcinoma cells in culture 165
Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients: Results from a multi-institutional study 165
Adult primary cervical rhabdomyosarcomas: A Multicentric cross-national case series 164
Anatomical Spaces in Radical Hysterectomy for Cervical Cancer 161
Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study 161
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 161
Neoadjuvant chemotherapy followed by radical surgery in locally advanced vulvar carcinoma: a single-institution experience 160
Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experience 159
Chlamydia trachomatis infection and HPV/Chlamydia trachomatis co-infection among HPV-vaccinated young women at the beginning of their sexual activity 159
Effectiveness of autologous blood transfusion in patients undergoing radical hysterectomy 156
Teniposide in refractory ovarian cancer: a phase II study 156
DNA index of ovarian carcinomas from 56 patients: In vivo in vitro studies 155
Reduction of postoperative complication rate with the use of early oral feeding in gynecologic oncologic patients undergoing a Major surgery: A randomized controlled trial 155
Randomized study between radical surgery and radiotherapy for the treatment of stage IB–IIA cervical cancer: 20-year update 154
Eviscerazione pelvica 154
Multidisciplinary approach in the management of advanced ovarian cancer patients: A personalized approach. Results from a specialized ovarian cancer unit 154
Endometriosis-related spontaneous hemoperitoneum in pregnancy: A case series 152
Molecular Detection of Human Papillomavirus (HPV) and Other Sexually Transmitted Pathogens in Cervical and Self-Collected Specimens 152
Phase II study of the platinum analog TNO-6 in patients with advanced ovarian cancer 150
The prognostic relevance of histological type in uterine sarcomas: A cooperation task force (CTF) multivariate analysis of 249 cases 148
Repair of the Perineal Defect After Radical Vulvar Surgery: Direct Closure Versus Skin Flaps Reconstruction: A Retrospective Comparative Study 147
Advanced low grade serous ovarian cancer: A retrospective analysis of surgical and chemotherapeutic management in two high volume oncological centers 146
Pelvic exenteration: Ten-year experience at the European Institute of Oncology in Milan 146
Effects of granulocyte-monocyte colony-stimulating factor (GM-CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer-associated macrophages 143
Platin-based chemotherapy and salvage surgery in recurrent ovarian cancer following negative second-look laparotomy 143
Evaluation of the interaction of mononuclear phagocytes with ovarian carcinoma cells in a colony assay 143
Radical Hysterectomy in Early-Stage Cervical Cancer: Abandoning the One-Fits-All Concept 141
The role of restaging borderline ovarian tumors: single institution experience and review of the literature 141
EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT) 140
Robotic approach for cervical cancer: comparison with laparotomy: a case control study 139
Poorly differentiated synovial sarcoma of the vagina: a case report and a clinical literature review 139
Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer 138
Totale 20.281
Categoria #
all - tutte 139.229
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.229


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.421 0 0 0 0 0 357 380 375 320 298 285 406
2021/20222.661 162 322 368 170 160 164 127 169 129 199 212 479
2022/20233.348 477 912 250 221 228 561 58 172 254 32 90 93
2023/20242.974 73 63 180 123 432 688 553 67 310 68 52 365
2024/20258.222 408 1.160 600 381 662 332 405 242 920 1.216 612 1.284
2025/20268.794 1.627 1.174 1.338 1.934 1.967 754 0 0 0 0 0 0
Totale 35.589